Tanja Blagus

Ljubljana, Slovenia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications

Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.

Genetic variants in purine metabolism and treatment resistance in schizophrenia: evidence supporting the adenosine hypothesis - a pilot study.

Journal: Frontiers in pharmacology
Published: May 08, 2026

Genetic variability of immune checkpoints in asbestos-related diseases.

Genetic variability of immune checkpoints in asbestos-related diseases.

Journal: Radiology and oncology
Published: April 09, 2026

PDE5A variation is associated with tadalafil response in men with diabetes mellitus and erectile dysfunction: a prospective proof-of-concept pharmacogenetic study.

PDE5A variation is associated with tadalafil response in men with diabetes mellitus and erectile dysfunction: a prospective proof-of-concept pharmacogenetic study.

Journal: The journal of sexual medicine
Published: March 13, 2026

Immune Infiltration, Effector T-Cell Enrichment, and Functional Context for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Immune Infiltration, Effector T-Cell Enrichment, and Functional Context for Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer.

Journal: International journal of molecular sciences
Published: January 31, 2026

Somatic Mutation Detection in Tumor Tissue and Matched Cell-Free DNA Using PCR-Based Methods in Pancreatic Cancer Patients Undergoing Upfront Resection.

Somatic Mutation Detection in Tumor Tissue and Matched Cell-Free DNA Using PCR-Based Methods in Pancreatic Cancer Patients Undergoing Upfront Resection.

Journal: International journal of molecular sciences
Published: August 04, 2025

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study.

Journal: EClinicalMedicine
Published: June 05, 2025

Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine.

Case Report: I want more olanzapine: pharmacogenetic insights into a patient's preference for high-dose olanzapine.

Journal: Frontiers in psychiatry
Published: May 22, 2025

The association of KEAP1 and NFE2L2 polymorphisms with glycemic control and late complications in patients with type 2 diabetes.

The association of KEAP1 and NFE2L2 polymorphisms with glycemic control and late complications in patients with type 2 diabetes.

Journal: Gene
Published: April 20, 2025

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice.

Genetic variability in sodium-glucose cotransporter 2 and glucagon-like peptide 1 receptor effect on glycemic and pressure control in type 2 diabetes patients treated with SGLT2 inhibitors and GLP-1RA in the everyday clinical practice.

Journal: Frontiers in endocrinology
Published: December 18, 2024

Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost.

Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost.

Journal: International journal of molecular sciences
Published: October 28, 2024

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Pharmacogenetic Implementation Studies-Lessons Learned From the PREPARE Study.

Journal: Clinical pharmacology and therapeutics
Published: September 19, 2024

Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy.

Genetic Variability in Oxidative Stress, Inflammatory, and Neurodevelopmental Pathways: Impact on the Susceptibility and Course of Spinal Muscular Atrophy.

Journal: Cellular and molecular neurobiology
Published: July 12, 2024
Showing 1-12 of 36

Last Updated: 09/26/2026